Vanderkerken, K: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Structure–activity relationships of poly(l-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery

Marjo Männistö, Sylvie Vanderkerken, Veska Toncheva, Matti Elomaa, Marika Ruponen, Etienne Schacht, Arto Urtti

Journal:

Journal of Controlled Release

Year:

2002

Language:

english

File:

PDF, 1009 KB

english, 2002

52

The crucial role of spacer groups in macromolecular prodrug design

Heidi Soyez, Etienne Schacht, Sylvie Vanderkerken

Journal:

Advanced Drug Delivery Reviews

Year:

1996

Language:

english

File:

PDF, 2.37 MB

english, 1996

53

In vivo homing and differentiation characteristics of mature (CD45−) and immature (CD45+) 5T multiple myeloma cells

Kewal Asosingh, Hendrik De Raeve, Peter Croucher, Eva Goes, Ivan Van Riet, Ben Van Camp, Karin Vanderkerken

Journal:

Experimental Hematology

Year:

2001

Language:

english

File:

PDF, 171 KB

english, 2001

54

Selective in vivo growth of lymphocyte function- associated antigen-1–positive murine myeloma cells: Involvement of function-associated antigen-1–mediated homotypic cell-cell adhesion

Kewal Asosingh, Virginie Vankerkhove, Ivan Van Riet, Ben Van Camp, Karin Vanderkerken

Journal:

Experimental Hematology

Year:

2003

Language:

english

File:

PDF, 286 KB

english, 2003

55

Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology

Fraczek Joanna, , Vinken Mathieu, Snykers Sarah, Deleu Sarah, Vanderkerken Karin, Vanhaecke Tamara, Rogiers Vera

Journal:

Journal of Cellular and Molecular Medicine

Year:

2009

Language:

english

File:

PDF, 1.04 MB

english, 2009

56

Multiple myeloma – an update on diagnosis and treatment

Jo Caers, Isabelle Vande broek, Hendrik De Raeve, Lucienne Michaux, Fabienne Trullemans, Rik Schots, Ben Van Camp, Karin Vanderkerken

Journal:

European Journal of Haematology

Year:

2008

Language:

english

File:

PDF, 296 KB

english, 2008

57

Geranylgeranyl transferase type II inhibition prevents myeloma bone disease

Michelle A. Lawson, Les Coulton, Frank H. Ebetino, Karin Vanderkerken, Peter I. Croucher

Journal:

Biochemical and Biophysical Research Communications

Year:

2008

Language:

english

File:

PDF, 382 KB

english, 2008

58

In vitro expanded bone marrow-derived murine (C57Bl/KaLwRij) mesenchymal stem cells can acquire CD34 expression and induce sarcoma formation in vivo

Song Xu, Ann De Becker, Hendrik De Raeve, Ben Van Camp, Karin Vanderkerken, Ivan Van Riet

Journal:

Biochemical and Biophysical Research Communications

Year:

2012

Language:

english

File:

PDF, 1.22 MB

english, 2012

59

Myeloma cells (5TMM) and their interactions with the marrow microenvironment

Eline Menu, Kewal Asosingh, Ivan Van Riet, Peter Croucher, Ben Van Camp, Karin Vanderkerken

Journal:

Blood Cells, Molecules, and Diseases

Year:

2004

Language:

english

File:

PDF, 202 KB

english, 2004

60

Blockade of the ALK1 receptor reduces tumour microvessel density and prevents the formation of osteolytic bone disease in the 5T2MM murine model of myeloma

A. Chantry, L. Coulton, O. Gallagher, H. Evans, J. Seehra, S. Pearsall, H. De Raeve, K. Vanderkerken, P. Croucher

Journal:

Year:

2009

Language:

english

File:

PDF, 60 KB

english, 2009

61

Localising individual myeloma cells to the myeloma ‘niche’ in bone using multiphoton microscopy

M.A. Lawson, A.J. Williams, T. Bos, K. Vanderkerken, P.I. Croucher

Journal:

Year:

2009

Language:

english

File:

PDF, 59 KB

english, 2009

62

Soluble RANK ligand produced by myeloma cells contributes to generalised bone loss in multiple myeloma

C.H. Buckle, E. De Leenheer, M.A. Lawson, J.M. Hough, K.L. Yong, N. Rabin, K. Vanderkerken, P.I. Croucher

Journal:

Year:

2009

Language:

english

File:

PDF, 88 KB

english, 2009

63

Inhibiting glycogen synthase kinase-3 (GSK-3) prevents the development of myeloma bone disease

N. Abdul, W. Stoop, W. Koopman, M. Djerbi, A.D. Chantry, H. Evans, K. Vanderkerken, P.I. Croucher

Journal:

Year:

2009

Language:

english

File:

PDF, 117 KB

english, 2009

64

Multiphoton imaging of individual myeloma cells in calvariae: Association of myeloma development with sites of bone turnover

A.J. Williams*, M.A. Lawson, O. Alamer, J. Hough, T. Bos, K. Vanderkerken, P.I. Croucher

Journal:

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

65

Laser-capture micro-dissection and gene array analysis to identify new molecules implicated in the development of myeloma bone disease

C. Buckle*, T. Andersen, J.-M. Delaisse, K. Vanderkerken, P.I. Croucher

Journal:

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

66

Bone marrow endothelial cells as active players in the pathobiology of multiple myeloma

K. Vanderkerken, E. De Bruyne, E. Menu, E. Van Valckenborgh, B. Van Camp

Journal:

Year:

2011

Language:

english

File:

PDF, 64 KB

english, 2011

67

Evidence of a role for RANKL in the development of myeloma bone disease

Evy De Leenheer, Gabrielle S Mueller, Karin Vanderkerken, Peter I Croucher

Journal:

Current Opinion in Pharmacology

Year:

2004

Language:

english

File:

PDF, 519 KB

english, 2004

68

P3. A soluble activin type II receptor prevents the development of myeloma bone disease

Andrew Chantry, Deborah Heath, Les Coulton, Holly Evans, Nicole Abdul, Jas Seehra, Karin Vanderkerken, Peter Croucher

Journal:

Cancer Treatment Reviews

Year:

2008

Language:

english

File:

PDF, 39 KB

english, 2008

69

OC7. Inhibiting dickkopf-1 (Dkk-1) prevents the development of osteolytic bone disease in multiple myeloma

Debby Heath, Andrew Chantry, Clive Buckle, Les Coulton, John Shaughnessy Jr., Holly Evans, David Stover, Karin Vanderkerken, Peter Croucher

Journal:

Cancer Treatment Reviews

Year:

2008

Language:

english

File:

PDF, 28 KB

english, 2008

70

Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myeloma

Dehui Xu, Jinsong Hu, Elke De Bruyne, Eline Menu, Rik Schots, Karin Vanderkerken, Els Van Valckenborgh

Journal:

Biochemical and Biophysical Research Communications

Year:

2012

Language:

english

File:

PDF, 978 KB

english, 2012

71

Involvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cells

Dianzhong Luo, David Vermijlen, Karin Vanderkerken, Peter J.K Kuppen, Carine Seynaeve, Mohammed Eddouks, Marijke Baekeland, Eddie Wisse

Journal:

Journal of Hepatology

Year:

1999

Language:

english

File:

PDF, 937 KB

english, 1999

72

B144 The Effect of JNJ-26481585 in Murine Myeloma Models

Deleu, SI, Arts, J, Lemaire, M, Menu, E, Van Valckenborgh, E, De Raeve, H, Croucher, P, Van Camp, B, Vanderkerken, K

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 96 KB

english, 2009

73

B145 BMSC-induced Drug Resistance by Arresting MM Cells at First Contact

Menu, E, Zebzda, A, Van Valckenborgh, E, Van Riet, I, Van Camp, B, Vanderkerken, K

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 115 KB

english, 2009

74

B216 Probing the Stem Cell in the 5T33 Multiple Myeloma Model

Van Valckenborgh, E, Babbage, G, Menu, E, Sahota, SS, Vanderkerken, K

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 120 KB

english, 2009

75

Defining Multiple Myeloma as a Target for DNA Fusion Gene Vaccines

Sahota, Surinder S., Zojer, Niklas, Babbage, Gavin, Joseph-Pietras, Deborah, Weston-Bell, Nicola, Vanderkerken, Karin, Sonneveld, Pieter, Klein, Bernard, Pulford, Karen, Rice, Jason, Savelyeva, Natali

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 82 KB

english, 2009

76

B552 The European Myeloma Stem Cell Network (MSCNET)

Johnsen, HE, Schmitz, A, Fogd, KB, Andersen, H, Vanderkerken, K, Valckenborgh, K, Sonneveld, EV, Duin, MV, Orfao, A, Hernandez-Campo,, Sanz, RG, Paiva, B, Sahota, S, Pietras, DJ, Weston-Bell, N, Babb

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 115 KB

english, 2009

77

Epigenetic Regulation of Multiple Myeloma Within its Bone Marrow Microenvironment

Vanderkerken, Karin, De Bruyne, Elke, Deleu, Sarah, Lemaire, Miguel, Menu, Eline, Van Valckenborgh, Els, Van Riet, Ivan, Van De Broek, Isabelle, Bos, Tomas, Van Camp, Ben

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 85 KB

english, 2009

78

How and When to Take Prostate Biopsies

Jan Vanderkerken, Jean de la Rosette, Pilar Laguna, Frans Debruyne

Journal:

European Urology Supplements

Year:

2002

Language:

english

File:

PDF, 156 KB

english, 2002

79

The role of adhesion molecules in the recruitment of hepatic natural killer cells (pit cells) in rat liver

D Luo, K Vanderkerken, L Bouwens, PJ Kuppen, M Baekeland, C Seynaeve, E Wisse

Journal:

Year:

1996

Language:

english

File:

PDF, 565 KB

english, 1996

80

The role of Kupffer cells in the differentiation process of hepatic natural killer cells

Karin Vanderkerken, Luc Bouwens, Nico Van Rooijen, Kit Van Den Berg, Marijke Baekeland, Eddie Wisse

Journal:

Year:

1995

Language:

english

File:

PDF, 2.81 MB

english, 1995

81

Of mice and men: disease models of multiple myeloma

Jo Caers, Kewal Asosingh, Ivan Van Riet, Benjamin Van Camp, Karin Vanderkerken

Journal:

Drug Discovery Today: Disease Models

Year:

2004

Language:

english

File:

PDF, 249 KB

english, 2004

82

Design of mechanisms of selective prodrug activation in the bone marrow microenvironment of experimental and human multiple myeloma

D.J. Mincher, E. Van Valckenborgh, L. Young, A. Turnbull, A. Di Salvo, K. Vanderkerken

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 89 KB

english, 2008

83

Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway

Xu, S, Evans, H, Buckle, C, De Veirman, K, Hu, J, Xu, D, Menu, E, De Becker, A, Vande Broek, I, Leleu, X, Camp, B V, Croucher, P, Vanderkerken, K, Van Riet, I

Journal:

Year:

2012

Language:

english

File:

PDF, 324 KB

english, 2012

84

THE USE OF GLYCERINE INSIDE THE UTERUS.

Bieghs, L., Maes, K., Van Valckenborgh, E., Menu, E., Johnsen, H.E., Nyegaard, M., Overgaard, M.T., Larson, O., Jernberg-Wiklund, H., Vanderkerken, K., De Bruyne, E.

Journal:

Year:

1903

Language:

english

File:

PDF, 171 KB

english, 1903

85

LIVERPOOL.

Bieghs, L., Maes, K., Van Valckenborgh, E., Menu, E., Johnsen, H.E., Nyegaard, M., Overgaard, M.T., Larson, O., Jernberg-Wiklund, H., Vanderkerken, K., De Bruyne, E.

Journal:

Year:

1896

Language:

english

File:

PDF, 199 KB

english, 1896

86

P01-24 The combination of the IGF-1 receptor inhibitor picropodophylin (PPP) and the BH3 mimetic ABT-737 has synergistic anti-myeloma activity

Bieghs, L., Maes, K., Van Valckenborgh, E., Menu, E., Johnsen, H.E., Nyegaard, M., Overgaard, M.T., Larson, O., Jernberg-Wiklund, H., Vanderkerken, K., De Bruyne, E.

Journal:

Growth Hormone & IGF Research

Year:

2012

Language:

english

File:

PDF, 55 KB

english, 2012

87

JOURNALS AND MAGAZINES.

Bieghs, L., Maes, K., Van Valckenborgh, E., Menu, E., Johnsen, H.E., Nyegaard, M., Overgaard, M.T., Larson, O., Jernberg-Wiklund, H., Vanderkerken, K., De Bruyne, E.

Journal:

Year:

1905

Language:

english

File:

PDF, 183 KB

english, 1905

88

Psychosocial interventions for reducing vocal challenging behavior in persons with autistic disorder: A multilevel meta-analysis of single-case experiments

Vanderkerken, Lien, Heyvaert, Mieke, Maes, Bea, Onghena, Patrick

Journal:

Research in Developmental Disabilities

Year:

2013

Language:

english

File:

PDF, 785 KB

english, 2013

89

Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma

Dutoit, Julie C., Vanderkerken, Matthias A., Verstraete, Koenraad L.

Journal:

European Journal of Radiology

Year:

2013

Language:

english

File:

PDF, 1.87 MB

english, 2013

90

Vorinostat-induced bone loss might be related to drug toxicity

Xu, Song, De Veirman, Kim, Vanderkerken, Karin, Van Riet, Ivan

Journal:

Year:

2013

Language:

english

File:

PDF, 176 KB

english, 2013

91

Ac-SDKP: Linking cardiac remodeling to hematological malignancies

Caers, Jo, Vanderkerken, Karin

Journal:

Leukemia and Lymphoma

Year:

2006

Language:

english

File:

PDF, 58 KB

english, 2006

92

Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells

Wang, J., Hendrix, A., Hernot, S., Lemaire, M., De Bruyne, E., Van Valckenborgh, E., Lahoutte, T., De Wever, O., Vanderkerken, K., Menu, E.

Journal:

Year:

2014

Language:

english

File:

PDF, 2.52 MB

english, 2014

93

The mouse bone marrow micronucleus assay can be used to distinguish aneugens from clastogens

Vanderkerken, K., Vanparys, Ph., Verschaeve, L., Kirsch-Volders, M.

Journal:

Year:

1989

Language:

english

File:

PDF, 2.55 MB

english, 1989

94

C-Banding as a Simple Tool to Discriminate Between Micronuclei Induced by Clastogens and Aneugens

Verschaeve, Luc, Vanderkerken, Karin, Kirsch-Volders, Micheline

Journal:

Biotechnic & Histochemistry

Year:

1988

Language:

english

File:

PDF, 209 KB

english, 1988

95

Tumor-initiating capacity of CD138− and CD138+ tumor cells in the 5T33 multiple myeloma model

Van Valckenborgh, E, Matsui, W, Agarwal, P, Lub, S, Dehui, X, De Bruyne, E, Menu, E, Empsen, C, van Grunsven, L, Agarwal, J, Wang, Q, Jernberg-Wiklund, H, Vanderkerken, K

Journal:

Year:

2012

Language:

english

File:

PDF, 296 KB

english, 2012

96

Dll1/Notch activation accelerates multiple myeloma disease development by promoting CD138+ MM-cell proliferation

Xu, D, Hu, J, Xu, S, De Bruyne, E, Menu, E, Van Camp, B, Vanderkerken, K, Van Valckenborgh, E

Journal:

Year:

2012

Language:

english

File:

PDF, 410 KB

english, 2012

97

Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo

Van Valckenborgh, E, De Raeve, H, Devy, L, Blacher, S, Munaut, C, Noël, A, Van Marck, E, Van Riet, I, Van Camp, B, Vanderkerken, K

Journal:

British Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 416 KB

english, 2002

98

Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor

Vande Broek, I, Vanderkerken, K, De Greef, C, Asosingh, K, Straetmans, N, Van Camp, B, Van Riet, I

Journal:

British Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 147 KB

english, 2001

99

Multiple myeloma induces the immunosuppressive capacity of distinct myeloid-derived suppressor cell subpopulations in the bone marrow

Van Valckenborgh, E, Schouppe, E, Movahedi, K, De Bruyne, E, Menu, E, De Baetselier, P, Vanderkerken, K, Van Ginderachter, J A

Journal:

Year:

2012

Language:

english

File:

PDF, 861 KB

english, 2012

100

Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies

Lemaire, M, D'Huyvetter, M, Lahoutte, T, Van Valckenborgh, E, Menu, E, De Bruyne, E, Kronenberger, P, Wernery, U, Muyldermans, S, Devoogdt, N, Vanderkerken, K

Journal:

Year:

2014

Language:

english

File:

PDF, 954 KB

english, 2014